ZUCCHI, RICCARDO
 Distribuzione geografica
Continente #
NA - Nord America 14.906
EU - Europa 7.267
AS - Asia 2.290
AF - Africa 281
OC - Oceania 18
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 5
Totale 24.776
Nazione #
US - Stati Uniti d'America 14.466
IT - Italia 2.465
SE - Svezia 1.489
CN - Cina 1.251
DE - Germania 877
BG - Bulgaria 709
CA - Canada 435
UA - Ucraina 402
GB - Regno Unito 334
VN - Vietnam 309
TR - Turchia 290
FI - Finlandia 258
CI - Costa d'Avorio 196
AT - Austria 174
SG - Singapore 171
CH - Svizzera 168
IN - India 101
FR - Francia 99
HK - Hong Kong 93
RU - Federazione Russa 79
BE - Belgio 58
SN - Senegal 40
NG - Nigeria 35
NL - Olanda 35
GR - Grecia 31
JP - Giappone 20
IR - Iran 19
AU - Australia 18
PL - Polonia 17
ES - Italia 12
IE - Irlanda 12
KR - Corea 11
DK - Danimarca 9
RO - Romania 8
AF - Afghanistan, Repubblica islamica di 6
CZ - Repubblica Ceca 6
EE - Estonia 6
EU - Europa 5
NO - Norvegia 5
PT - Portogallo 5
SA - Arabia Saudita 4
BR - Brasile 3
CL - Cile 3
EG - Egitto 3
IL - Israele 3
TW - Taiwan 3
ID - Indonesia 2
MA - Marocco 2
MK - Macedonia 2
MT - Malta 2
MX - Messico 2
PH - Filippine 2
ZA - Sudafrica 2
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CO - Colombia 1
DM - Dominica 1
GH - Ghana 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IQ - Iraq 1
KW - Kuwait 1
KZ - Kazakistan 1
LT - Lituania 1
MS - Montserrat 1
MU - Mauritius 1
MY - Malesia 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 24.776
Città #
Woodbridge 2.371
Ann Arbor 1.638
Houston 1.353
Fairfield 1.341
Chandler 1.302
Milan 811
Ashburn 765
Sofia 707
Jacksonville 570
Seattle 541
Wilmington 527
Cambridge 450
Beijing 449
New York 418
Ottawa 406
Serra 349
Princeton 342
Lawrence 277
Izmir 264
Nanjing 255
Medford 220
Abidjan 196
Dearborn 189
Vienna 167
Bern 158
Des Moines 144
Frankfurt am Main 129
Dong Ket 126
Pisa 118
Jüchen 102
Bremen 101
Florence 97
Redwood City 89
Hong Kong 85
Nanchang 83
Kunming 76
San Diego 76
Boulder 74
Rome 67
Brussels 57
London 49
Lancaster 47
Pune 47
Shenyang 42
Dakar 40
Los Angeles 39
Norwalk 36
Lagos 35
Changsha 34
Hebei 32
Ogden 32
Hefei 31
Nürnberg 31
Tianjin 31
Jiaxing 30
Boardman 27
Singapore 26
Orange 24
Washington 24
Guangzhou 23
Falls Church 22
Livorno 18
Toronto 18
Hangzhou 16
Kocaeli 16
Renton 15
Bologna 14
Grosseto 13
Jinan 13
Marseille 13
Phoenix 13
Verona 13
Warsaw 12
Shanghai 11
Vicopisano 11
Xian 11
Auburn Hills 10
Chicago 10
San Francisco 10
Chengdu 8
Guiyang 8
Lucca 8
Shenzhen 8
Thrissur 8
Zhengzhou 8
Dublin 7
Düsseldorf 7
Lanzhou 7
North York 7
Portland 7
Tappahannock 7
Wuhan 7
Changchun 6
Chennai 6
Dallas 6
Follonica 6
Grafing 6
Hobart 6
Rødovre 6
Tallinn 6
Totale 18.574
Nome #
null 236
Thyroid hormone levels in the cerebrospinal fluid correlate with disease severity in euthyroid patients with Alzheimer's disease 213
Tissue thyroid hormones and thyronamines 201
Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases 180
3-Iodothyronamine affects calcium handling in rat ventricular cardiomyocytes 170
The effect of high glucose on the inhibitory action of C21, a selective AT2R agonist, of LPS-stimulated tissue factor expression in human mononuclear cells 165
3-Iodothyronamine modulates sarcoplasmic reticulum calcium release 161
Adenine nucleotide depletion and contractile dysfunction in the "stunned" myocardium 156
Cardiac actions of thyroid hormone metabolites 153
Stimulation of cardiac trace amine receptors by 3-iodothyronamine modulates tyrosine phosphorylation and induces cardioprotection 152
Exogenous 3-iodothyronamine rescues the entorhinal cortex from β-amyloid toxicity 150
Modulation of Gene Expression by 3-Iodothyronamine: Genetic Evidence for a Lipolytic Pattern 145
Uric acid and purine compounds in aortic and coronary sinus blood in man 143
Effect of acute and chronic zofenopril administration on cardiac gene expression 143
Stimulation of cardiac trace amine receptors by 3-iodothyronamine modulates tyrosine phosphorylation and induces cardioprotection 140
Cardioprotection by 3-iodothyronamine, a new endogenous chemical messenger 139
3-Iodothyronamine (T(1)AM) induces variation in phosphorylation pattern of tyrosine residues in rat heart 139
Are dihydropyridine receptors downregulated in the ischemic myocardium? 139
3-Iodothyronamine as a novel endogenous chemical messenger: tissue distribution and catabolism 138
3-Iodothyronamine as a Novel Endogenous Chemical Messenger: Tissue Distribution and Catabolism. 136
Thyronamines and Derivatives: Physiological Relevance, Pharmacological Actions, and Future Research Directions 136
Compound 21, a selective angiotensin II type 2 receptor agonist, downregulates lipopolysaccharide-stimulated tissue factor expression in human peripheral blood mononuclear cells. 134
Quantification of dehydroepiandrosterone in human serum on a routine basis: development and validation of a tandem mass spectrometry method based on a surrogate analyte 132
Assay of endogenous 3,5-diiodo-L-thyronine (3,5-T2) and 3,3’-diiodo-L-thyronine (3,3’-T2) in human serum: a feasibility study 132
Non enzymatic upregulation of tissue factor expression by gamma-glutamyl transferase in human peripheral blood mononuclear cells 131
Cardioprotective effect of 3-iodothyronamine in perfused rat heart subjected to ischemia and reperfusion. 131
Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart 130
Cardiac effects of trace amines: pharmacological characterization of trace amine-associated receptors 130
Hypovitaminosis D in patients with heart failure: effects on functional capacity and patients' survival 130
Purine release from isolated rat heart: a new approach to the study of energy metabolism 128
Effect of ischaemia on cardiac adenosine binding sites 128
3-Iodothyronamine affects calcium handling in isolated cardiomyocytes 128
The case for TAAR1 as a modulator of central nervous system function 128
Energy metabolism in myocardial stunning 127
Modulation of Cardiac Inotropic State by 3-Iodothyronamine: Evidence for a Novel Signalling Pathway Mediated by Trace Amine-Associated Receptors 127
Effect of MEN 10755, a new disaccharide analogue of doxorubicin, on sarcoplasmic reticulum Ca(2+) handling and contractile function in rat heart 127
New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection 126
Effect of gallopamil on cardiac sarcoplasmic reticulum 125
Modulation of sarcoplasmic reticulum calcium channel by adenosine: a PKC-dependent pathway 125
3-Iodothyronamine Modulates Sarcoplasmic Reticulum Calcium Release 124
The adenosine hypothesis revisited: relationship between purine release and coronary flow in isolated rat heart 122
Endogenous TH metabolite 3-iodothyronamine (T1AM) and synthetic thyronamine-like analogues SG-1 and SG-2 induce autophagy in human glioblastoma cells (U-87MG) 121
Effect of volatile anesthetics on ryanodine binding in skeletal muscle 120
Administration of 3-Iodothyronamine (T1AM) Affects Gene Expression in the Rat Adipose Tissue Cells. 120
Distribution of exogenous [125I]-3-iodothyronamine in mouse in vivo: relationship with trace amine-associated receptors. 119
Effect of Hypothyroidism and Hyperthyroidism on Tissue Thyroid Hormone Concentrations in Rat 119
Effects of verapamil, gallopamil, diltiazem and nifedipine on sarcoplasmic reticulum function in rat heart 118
null 118
Effects of 3-iodothyronamine (T1AM) on signaling pathways involved in synaptic plasticity and neuroprotection. 118
A new signalling pathway mediated by 3-iodothyronamine in rat heart 117
Characterization of 3-Iodothyronamine In Vitro Dynamics by Mathematical Modeling 117
3-iodothyroacetic acid, a metabolite of thyroid hormone, induces itch and reduces threshold to noxious and to painful heat stimuli in mice. 117
Influence of energy metabolism on cardiac purine release 116
A3 adenosine receptor stimulation modulates sarcoplasmic reticulum Ca2+ release in rat heart 116
Metabolic reprogramming by 3-Iodothyronamine (T1AM): a new perspective to reverse obesity through co-regulation of sirtuin 4 and 6 expression 116
A1 receptor stimulation induces changes in calcium homeostasis 115
3-Iodothyronamine (T1AM) signalling pathway involves tyrosine phosphorylation in rat heart 115
Cardioprotective effect of growth hormone secretagogues in rat heart 115
Phosphocreatine as a possible modulator of the adenylate pool 114
F(0) F(1) -Atpsynthase as a Molecular Target of 3-Iodothyronamine 114
Protection of ischemic rat heart by dantrolene, an antagonist of the sarcoplasmic reticulum calcium release channel 114
Cardiac toxicity of antineoplastic anthracyclines 114
Cardioprotection by ranolazine in perfused rat heart 114
Cardioprotection by ouabain and digoxin in perfused rat hearts 114
null 114
Cardiac A2 adenosine receptors - influence of ischemia 113
Forskolin and myocardial function in the normal, ischemic and reperfused rat heart 112
Acute Infusion of recombinant human thyrotropin in Langendorff-rat hearts:Role of a thyrotropin receptor 112
In the brain of mice, 3-iodothyronamine (T1AM) is converted into 3-iodothyroacetic acid (TA1) and it is included within the signaling network connecting thyroid hormone metabolites with histamine 111
Gamma-Glutamyltransferase Stimulates Tissue Factor Expression Independent of its Enzymatic Activity in Human Mononuclear Cells 111
Effects of A1 adenosine receptor stimulation on the expression of genes involved in calcium homeostasis 111
3-iodothyronamine is a novel endogenous modulator of cardiac inotropic state 110
A1 adenosine receptor stimulates phospholamban expression 110
3-Iodothyronamine (T1AM) modifies tyrosine phosphorylation pattern in rat heart 110
3-Iodothyronamine (T1AM) induces variation in the phosphorylation pattern of thyrosine residues in rat heart 110
New Insights into the Effects of 3-Iodothyronamine (T1AM) on Metabolism in Mice from Cavity Ring Down Spectroscopy (CRDS) 110
Detection of 3-Iodothyronamine in human patients: a preliminary study 108
Effect of carnitine and coenzyme Q10 on the calcium uptake in heart sarcoplasmic reticulum of rats treated with anthracyclines 108
Effect of amrinone in the working rat heart: influence of ischemic damage, adenosine and calcium 107
Echocardiographic assessment of infarct size: reduction after nitrates therapy 107
Cardioprotective effect of growth hormone secretagogues in rat heart 107
Metabolic profiling reveals reprogramming of lipid metabolic pathways in treatment of polycystic ovary syndrome with 3-iodothyronamine 107
ACE2 in the era of SARS-CoV-2: controversies and novel perspectives 107
Effect of cardiac A1 adenosine receptor overexpression on sarcoplasmic reticulum function 106
WEIGHT LOSS WITH PRESERVED GLUCOSE HOMEOSTASIS DURING CHRONIC TREATMENT OF OBESE MICE WITH 3-IODOTHYRONAMINE (T1AM): ROLE OF THE SIRTUIN FAMILY 106
3-Iodothyronamine rescues beta-amyloid dependent long term potentiation impairment in the enthorinal cortex 105
3-iodothyronamine as a potential anti-tumor compound 105
Modulation of cardiac inotropic state by 3-iodothyronamine: evidence for a novel signalling pathway mediated by trace amine-associated receptors 104
Protection of isolated perfused working rat heart from oxidative stress by exogenous L-propionyl carnitine 102
La protezione del miocardio ischemico 102
Evaluation of 3-iodothyronamine (T1AM) in cell preparation, tissue homogenates and biological fluids by HPLC-ESI-MS-MS 102
Modulation of sarcoplasmic reticulum function: a new strategy in cardioprotection? 102
Elaborazione computerizzata della ventricolografia sinistra e della coronarografia 101
Modulation of the cardiac sarcoplasmic reticulum release by adenosine: a protein kinase C-dependent pathway 101
Restoration of cardiac tissue thyroid hormone status in experimental hypothyroidism: a dose-response study in female rats 101
Recovery of 3-iodothyronamine and derivatives in biological matrices: problems and pitfalls 101
Modulation of cardiac calcium homeostasis by 3-iodothyronamine 101
Altered autonomic cardiac control in hypertrophic cardiomyopathy 100
Cardiac metabolism of 3-iodothyronamine 100
Tissue Distribution and Cardiac Metabolism of 3-Iodothyronamine 100
Totale 12.405
Categoria #
all - tutte 57.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.170


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.411 0 0 0 0 0 0 0 0 0 509 507 395
2019/20204.170 538 385 204 276 390 500 468 289 414 259 377 70
2020/20212.326 221 94 262 109 255 119 149 224 188 201 125 379
2021/20223.120 50 181 66 212 572 401 70 157 169 100 264 878
2022/20234.155 518 557 322 420 433 546 39 266 748 27 224 55
2023/20242.778 456 355 430 218 464 526 100 116 64 49 0 0
Totale 25.255